Activity
| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
6 actions
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ataxia and cerebellar anomalies - childhood onset v9.35 | PAX6 |
Luke Stuart changed review comment from: Early literature suspected PAX6 as the causative gene for Gillespie syndrome (partial aniridia, cerebellar ataxia, and mental retardation), but direct sequencing repeatedly found no PAX6 mutations in classic Gillespie cases. Linkage analysis in affected families showed the disease trait segregates independently from chromosome 11p markers flanking PAX6 (Glaser et al., 1994; PMID 8188215). The causative gene was identified as ITPR1. PAX6 biallelic loss-of-function causes a severe, prenatal/neonatal-onset neurodevelopmental disorder characterised by anophthalmia/microphthalmia and major CNS malformations, including agenesis of the corpus callosum, olfactory bulb aplasia/hypoplasia, brainstem hypoplasia, cortical malformations, and cerebellar dysplasia/hypoplasia; reported cases were stillborn or died in the neonatal period, with only rare survival despite profound developmental abnormalities (Glaser et al., 1994, PMID: 7951315; Schmidt-Sidor et al., 2009, PMID: 20054790; Solomon et al., 2010, PMID: 19876904). Thus, biallelic PAX6-related disease is not within scope for the paediatric onset ataxia/ cerebellar anomalies panels. Isolated reports describe heterozygous PAX6 variants associated with neurological manifestations, including ataxia or cerebellar dysfunction: Ticho et al., 2006 (PMID: 17148041): A patient described as having "atypical Gillespie syndrome" presented with mild hand tremor and learning disability but no reported ataxia or structural cerebellar abnormalities on neuroimaging. Sequencing identified a heterozygous PAX6 splice-site variant, IVS2+2T>A. Graziano et al., 2007 (PMID 17595013): described a 9.5-year-old girl with bilateral aniridia, ataxia, and intellectual disability; she carried a de novo heterozygous nonsense variant, PAX6 p.(Trp257Ter). Dansault et al., 2007 (PMID 17417613): In a large family carrying the c.655A>G p.S74G variant, all affected individuals exhibited a mild but consistent cerebellar syndrome. The most severely affected individual had a clear static cerebellar syndrome. MRI findings included hypoplasia of the anterior commissure and absence of the pineal gland in one individual. Despite the consistent neurological phenotype, no specific structural cerebellar abnormalities were identified. Conclusion: Two unrelated PAX6 families with heterozygous variants showed evidence ataxia and/or a cerebellar syndrome phenotype, the latter without any recognisable cerebellar malformation. PAX6 knockout mice delineate a primary role of PAX6 in cerebellar development, though are not known to recapitulate an ataxia phenotype, nor cerebellar phenotype in the context of haploinsufficiency (Schmahl et al., 1993; PMID 8213068; Quinn et al., 2007; PMID 16979618)). An amber rating with monoallelic inheritance is proposed.; to: Early literature suspected PAX6 as the causative gene for Gillespie syndrome (partial aniridia, cerebellar ataxia, and mental retardation), but direct sequencing repeatedly found no PAX6 mutations in classic Gillespie cases. Linkage analysis in affected families showed the disease trait segregates independently from chromosome 11p markers flanking PAX6 (Glaser et al., 1994; PMID 8188215). The causative gene was identified as ITPR1. PAX6 biallelic loss-of-function causes a severe, prenatal/neonatal-onset neurodevelopmental disorder characterised by anophthalmia/microphthalmia and major CNS malformations, including agenesis of the corpus callosum, olfactory bulb aplasia/hypoplasia, brainstem hypoplasia, cortical malformations, and cerebellar dysplasia/hypoplasia; reported cases were stillborn or died in the neonatal period, with only rare survival despite profound developmental abnormalities (Glaser et al., 1994, PMID: 7951315; Schmidt-Sidor et al., 2009, PMID: 20054790; Solomon et al., 2010, PMID: 19876904). A rare paediatric report described a 4-year-old proband with compound heterozygous PAX6 variants (1x missense affecting the paired domain and 1x nonsense); they presented with structural brain anomalies including agenesis of the corpus callosum, hypoplastic pons and vermis (absent inferiorly), possible Dandy-Walker malformation, pituitary and hypothalamic hypoplasia; attribution of these phenotypic features to PAX6 is confounded by the proband's dual diagnosis including trisomy 21 (Solomon et al., 2009 (PMID 19876904). Isolated reports describe heterozygous PAX6 variants associated with neurological manifestations, including ataxia or cerebellar dysfunction: Ticho et al., 2006 (PMID: 17148041): A patient described as having "atypical Gillespie syndrome" presented with mild hand tremor and learning disability but no reported ataxia or structural cerebellar abnormalities on neuroimaging. Sequencing identified a heterozygous PAX6 splice-site variant, IVS2+2T>A. Graziano et al., 2007 (PMID 17595013): described a 9.5-year-old girl with bilateral aniridia, ataxia, and intellectual disability; she carried a de novo heterozygous nonsense variant, PAX6 p.(Trp257Ter). Dansault et al., 2007 (PMID 17417613): In a large family carrying the c.655A>G p.S74G variant, all affected individuals exhibited a mild but consistent cerebellar syndrome. The most severely affected individual had a clear static cerebellar syndrome. MRI findings included hypoplasia of the anterior commissure and absence of the pineal gland in one individual. Despite the consistent neurological phenotype, no specific structural cerebellar abnormalities were identified. Conclusion: Two unrelated PAX6 families with heterozygous variants showed evidence ataxia and/or a cerebellar syndrome phenotype, the latter without any recognisable cerebellar malformation. PAX6 knockout mice delineate a primary role of PAX6 in cerebellar development, though are not known to recapitulate an ataxia phenotype, nor cerebellar phenotype in the context of haploinsufficiency (Schmahl et al., 1993; PMID 8213068; Quinn et al., 2007; PMID 16979618)). An amber rating with monoallelic inheritance is proposed. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ataxia and cerebellar anomalies - childhood onset v9.35 | PAX6 |
Luke Stuart changed review comment from: Early literature suspected PAX6 as the causative gene for Gillespie syndrome (partial aniridia, cerebellar ataxia, and mental retardation), but direct sequencing repeatedly found no PAX6 mutations in classic Gillespie cases. Linkage analysis in affected families showed the disease trait segregates independently from chromosome 11p markers flanking PAX6 (Glaser et al., 1994; PMID 8188215). |The sausative gene was identified as ITPR1. PAX6 biallelic loss-of-function causes a severe, prenatal/neonatal-onset neurodevelopmental disorder characterised by anophthalmia/microphthalmia and major CNS malformations, including agenesis of the corpus callosum, olfactory bulb aplasia/hypoplasia, brainstem hypoplasia, cortical malformations, and cerebellar dysplasia/hypoplasia; reported cases were stillborn or died in the neonatal period, with only rare survival despite profound developmental abnormalities (Glaser et al., 1994, PMID: 7951315; Schmidt-Sidor et al., 2009, PMID: 20054790; Solomon et al., 2010, PMID: 19876904). Thus, biallelic PAX6-related disease is not within scope for the paediatric onset ataxia/ cerebellar anomalies panels. Isolated reports describe heterozygous PAX6 variants associated with neurological manifestations, including ataxia or cerebellar dysfunction: Ticho et al., 2006 (PMID: 17148041): A patient described as having "atypical Gillespie syndrome" presented with mild hand tremor and learning disability but no reported ataxia or structural cerebellar abnormalities on neuroimaging. Sequencing identified a heterozygous PAX6 splice-site variant, IVS2+2T>A. Graziano et al., 2007 (PMID 17595013): described a 9.5-year-old girl with bilateral aniridia, ataxia, and intellectual disability; she carried a de novo heterozygous nonsense variant, PAX6 p.(Trp257Ter). Dansault et al., 2007 (PMID 17417613): In a large family carrying the c.655A>G p.S74G variant, all affected individuals exhibited a mild but consistent cerebellar syndrome. The most severely affected individual had a clear static cerebellar syndrome. MRI findings included hypoplasia of the anterior commissure and absence of the pineal gland in one individual. Despite the consistent neurological phenotype, no specific structural cerebellar abnormalities were identified. Conclusion: Two unrelated PAX6 families with heterozygous variants showed evidence ataxia and/or a cerebellar syndrome phenotype, the latter without any recognisable cerebellar malformation. PAX6 knockout mice delineate a primary role of PAX6 in cerebellar development, though are not known to recapitulate an ataxia phenotype, nor cerebellar phenotype in the context of haploinsufficiency (Schmahl et al., 1993; PMID 8213068; Quinn et al., 2007; PMID 16979618)). An amber rating with monoallelic inheritance is proposed.; to: Early literature suspected PAX6 as the causative gene for Gillespie syndrome (partial aniridia, cerebellar ataxia, and mental retardation), but direct sequencing repeatedly found no PAX6 mutations in classic Gillespie cases. Linkage analysis in affected families showed the disease trait segregates independently from chromosome 11p markers flanking PAX6 (Glaser et al., 1994; PMID 8188215). The causative gene was identified as ITPR1. PAX6 biallelic loss-of-function causes a severe, prenatal/neonatal-onset neurodevelopmental disorder characterised by anophthalmia/microphthalmia and major CNS malformations, including agenesis of the corpus callosum, olfactory bulb aplasia/hypoplasia, brainstem hypoplasia, cortical malformations, and cerebellar dysplasia/hypoplasia; reported cases were stillborn or died in the neonatal period, with only rare survival despite profound developmental abnormalities (Glaser et al., 1994, PMID: 7951315; Schmidt-Sidor et al., 2009, PMID: 20054790; Solomon et al., 2010, PMID: 19876904). Thus, biallelic PAX6-related disease is not within scope for the paediatric onset ataxia/ cerebellar anomalies panels. Isolated reports describe heterozygous PAX6 variants associated with neurological manifestations, including ataxia or cerebellar dysfunction: Ticho et al., 2006 (PMID: 17148041): A patient described as having "atypical Gillespie syndrome" presented with mild hand tremor and learning disability but no reported ataxia or structural cerebellar abnormalities on neuroimaging. Sequencing identified a heterozygous PAX6 splice-site variant, IVS2+2T>A. Graziano et al., 2007 (PMID 17595013): described a 9.5-year-old girl with bilateral aniridia, ataxia, and intellectual disability; she carried a de novo heterozygous nonsense variant, PAX6 p.(Trp257Ter). Dansault et al., 2007 (PMID 17417613): In a large family carrying the c.655A>G p.S74G variant, all affected individuals exhibited a mild but consistent cerebellar syndrome. The most severely affected individual had a clear static cerebellar syndrome. MRI findings included hypoplasia of the anterior commissure and absence of the pineal gland in one individual. Despite the consistent neurological phenotype, no specific structural cerebellar abnormalities were identified. Conclusion: Two unrelated PAX6 families with heterozygous variants showed evidence ataxia and/or a cerebellar syndrome phenotype, the latter without any recognisable cerebellar malformation. PAX6 knockout mice delineate a primary role of PAX6 in cerebellar development, though are not known to recapitulate an ataxia phenotype, nor cerebellar phenotype in the context of haploinsufficiency (Schmahl et al., 1993; PMID 8213068; Quinn et al., 2007; PMID 16979618)). An amber rating with monoallelic inheritance is proposed. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ataxia and cerebellar anomalies - childhood onset v3.16 | TPR | Achchuthan Shanmugasundram edited their review of gene: TPR: Changed rating: RED | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ataxia and cerebellar anomalies - childhood onset v3.16 | TPR |
Achchuthan Shanmugasundram gene: TPR was added gene: TPR was added to Ataxia and cerebellar anomalies - narrow panel. Sources: Literature Mode of inheritance for gene: TPR was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TPR were set to 34494102 Phenotypes for gene: TPR were set to Cerebellar ataxia, MONDO:0000437 Added comment: Comment on classification of this gene: This gene should be added with a RED rating as the association of TPR to ataxia is based on biallelic variants identified from a report of two siblings. Two siblings harbouring variants c.6625C>T/ p.Arg2209Ter (identified in heterozygous state in both siblings and father) and c.2610 + 5G > A (identified in heterozygous state in both siblings and mother) were reported with ataxia, microcephaly and severe intellectual disability. Functional analyses in patient fibroblasts provide evidence that the variants affect TPR splicing, reduce steady-state TPR levels, abnormal nuclear pore composition and density, and altered global RNA distribution. This gene has not yet been associated with any phenotypes either in OMIM or in Gene2Phenotype. Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ataxia and cerebellar anomalies - childhood onset v0.5 | ITPR1 |
Ellen McDonagh Mode of pathogenicity for gene ITPR1 was changed from to Other - please provide details in the comments Added phenotypes Spinocerebellar ataxia 29; Spinocerebellar ataxia 15 for gene: ITPR1 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ataxia and cerebellar anomalies - childhood onset v0.5 | ITPR1 |
Ellen McDonagh gene: ITPR1 was added gene: ITPR1 was added to Ataxia and cerebellar anomalies - narrow panel. Sources: Expert Review Green Mode of inheritance for gene: ITPR1 was set to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal Phenotypes for gene: ITPR1 were set to Gillespie syndrome 206700; Spinocerebellar ataxia 15; Spinocerebellar ataxia 29, congenital nonprogressive |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||